Literature DB >> 623082

Sweat electrolytes in chronic pancreatitis.

S Bank, I N Marks, B Novis.   

Abstract

Sweat electrolytes were carried out in 84 adult patients with calcific pancreatitis, 51 with noncalcific pancreatitis, and the results compared to 37 adult controls. Of the patients with calcific pancreatitis, 33.5% had sweat sodium levels greater than 90 mEq/liter and 14.4% a level greater that 120 mEq/liter. Patients with noncalcific pancreatitis also had a high incidence of elevated sweat sodium levels. Sweat potassium levels were less discriminating, and there appeared to be high sweat calcium levels in a few patients so tested. The reasons for the elevated sweat sodium levels in pancreatitis is not readily apparent, and the possible relationship to heterozygous forms of cystic fibrosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623082     DOI: 10.1007/bf01073197

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  13 in total

1.  THE PANCREATIC-FUNCTION TEST--METHOD AND NORMAL VALUES.

Authors:  S BANK; I N MARKS; M G MOSHAL; G EFRON; R SILBER
Journal:  S Afr Med J       Date:  1963-10-19

2.  THE AETIOLOGY, CLINICAL FEATURES AND DIAGNOSIS OF PANCREATITIS IN THE SOUTH WESTERN CAPE; A REVIEW OF 243 CASES.

Authors:  I N MARKS; S BANK
Journal:  S Afr Med J       Date:  1963-10-19

3.  The clinical significance of circulating pancreatic antibodies.

Authors:  M J MURRAY; A P THAL
Journal:  Ann Intern Med       Date:  1960-09       Impact factor: 25.391

4.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

5.  Mucoviscidosis as a factor in chronic lung disease in adults.

Authors:  A J KARLISH; A L TARNOKY
Journal:  Lancet       Date:  1960-09-03       Impact factor: 79.321

6.  Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease.

Authors:  P A DI SANT'AGNESE; R C DARLING; G A PERERA; E SHEA
Journal:  Pediatrics       Date:  1953-11       Impact factor: 7.124

7.  Precalcific pancreatitis.

Authors:  S Bank; I N Marks; B Lurie; B H Novis; G O Barbezat
Journal:  S Afr Med J       Date:  1972-12-30

8.  Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis.

Authors:  H Sarles; J C Sarles; R Camatte; R Muratore; M Gaini; C Guien; J Pastor; F Le Roy
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

9.  Serum immunoglobulin levels in cystic fibrosis.

Authors:  R H Schwartz
Journal:  Am J Dis Child       Date:  1966-04

10.  Serum immunoglobulins in calcific pancreatitis.

Authors:  S Bank; B H Novis; E Petersen; E Dowdle; I N Marks
Journal:  Gut       Date:  1973-09       Impact factor: 23.059

View more
  5 in total

Review 1.  Cystic fibrosis--a gastroenterological cornucopia.

Authors:  P L Zentler-Munro
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

Review 2.  Cystic fibrosis in the pancreas: recent advances provide new insights.

Authors:  J D Bornstein; J A Cohn
Journal:  Curr Gastroenterol Rep       Date:  1999-04

3.  Common denominators in the etiology and pathology of visceral lesions of cystic fibrosis and Keshan disease.

Authors:  J D Wallach; M Lan; W H Yu; B Q Gu; F T Yu; R F Goddard
Journal:  Biol Trace Elem Res       Date:  1990-03       Impact factor: 3.738

Review 4.  Chronic pancreatitis and cystic fibrosis.

Authors:  H Witt
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 5.  Wearable Sweat Loss Measuring Devices: From the Role of Sweat Loss to Advanced Mechanisms and Designs.

Authors:  Bowen Zhong; Kai Jiang; Lili Wang; Guozhen Shen
Journal:  Adv Sci (Weinh)       Date:  2021-10-28       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.